Edwards Lifesciences Corp
Symbol: EW (NYSE)
Company Description:
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
- Today's Open: $76.8
- Today's High: $78.265
- Today's Low: $75.645
- Today's Volume: 6.02M
- Yesterday Close: $76.02
- Yesterday High: $76.095
- Yesterday Low: $74.69
- Yesterday Volume: 3.79M
- Last Min Volume: 287.56K
- Last Min High: $76.795
- Last Min Low: $76.795
- Last Min VWAP: $76.795
- Name: Edwards Lifesciences Corp
- Website: https://www.edwards.com
- Listed Date: 2000-04-03
- Location: IRVINE, CA
- Market Status: Active
- CIK Number: 0001099800
- SIC Code: 3842
- SIC description: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
- Market Cap: $44.63B
- Round Lot: 100
- Outstanding Shares: 587.10M
- Asset Type: CS
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-17 | SCHEDULE 13G/A | View |
| 2025-10-16 | 144 | View |
| 2025-09-15 | 4 | View |
| 2025-09-15 | 4 | View |
| 2025-09-15 | 4 | View |
| 2025-08-25 | 4 | View |
| 2025-08-25 | 144 | View |
| 2025-08-19 | 8-K | View |
| 2025-08-18 | 4 | View |
| 2025-08-18 | 144 | View |
| 2025-08-12 | SCHEDULE 13G/A | View |
| 2025-08-06 | S-8 | View |
| 2025-08-06 | S-8 | View |
| 2025-08-06 | 10-Q | View |
| 2025-08-06 | 8-K | View |
| 2025-07-28 | 4 | View |
| 2025-07-28 | 144 | View |
| 2025-07-25 | 8-K | View |
| 2025-07-24 | 8-K | View |
| 2025-07-21 | S-3ASR | View |
